Literature DB >> 32069911

Bone Marrow Stromal Cell-Derived IL-8 Upregulates PVR Expression on Multiple Myeloma Cells via NF-kB Transcription Factor.

Abdelilah Mekhloufi1, Andrea Kosta1, Helena Stabile1, Rosa Molfetta1, Alessandra Zingoni1, Alessandra Soriani1, Marco Cippitelli1, Rossella Paolini1, Angela Gismondi1, Maria Rosaria Ricciardi2, Maria Teresa Petrucci2, Laura Masuelli3, Giulio Caracciolo1, Sara Palchetti1, Angela Santoni1,4, Cinzia Fionda1.   

Abstract

Bone marrow stromal cells (BMSCs) strongly contribute to multiple myeloma (MM) progression, promoting the survival and growth of malignant plasma cells (PCs). However, the possible impact of these cells on the immune-mediated recognition of MM cells remains largely unknown. DNAM-1 activating receptor plays a prominent role in NK cell anti-MM response engaging the ligands poliovirus receptor (PVR) and nectin-2 on malignant PCs. Here, we analysed the role of MM patient-derived BMSCs in the regulation of PVR expression. We found that BMSCs enhance PVR surface expression on MM cells and promote their NK cell-mediated recognition. PVR upregulation occurs at transcriptional level and involves NF-kB transcription factor activation by BMSC-derived soluble factors. Indeed, overexpression of a dominant-negative mutant of IKBα blocked PVR upregulation. IL-8 plays a prominent role in these mechanisms since blockade of CXCR1/2 receptors as well as depletion of the cytokine via RNA interference prevents the enhancement of PVR expression by BMSC-derived conditioned medium. Interestingly, IL-8 is associated with stromal microvesicles which are also required for PVR upregulation via CXCR1/CXCR2 signaling activation. Our findings identify BMSCs as regulators of NK cell anti-MM response and contribute to define novel molecular pathways involved in the regulation of PVR expression in cancer cells.

Entities:  

Keywords:  IL-8; PVR; bone marrow stromal cells; multiple myeloma; natural killer cells

Year:  2020        PMID: 32069911     DOI: 10.3390/cancers12020440

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  10 in total

Review 1.  Mesenchymal Stem Cell Immunomodulation: A Novel Intervention Mechanism in Cardiovascular Disease.

Authors:  Yueyao Wang; Zhongwen Qi; Zhipeng Yan; Nan Ji; Xiaoya Yang; Dongjie Gao; Leilei Hu; Hao Lv; Junping Zhang; Meng Li
Journal:  Front Cell Dev Biol       Date:  2022-01-12

2.  A Hyaluronan and Proteoglycan Link Protein 1 Matrikine: Role of Matrix Metalloproteinase 2 in Multiple Myeloma NF-κB Activation and Drug Resistance.

Authors:  Christina Mark; Jay Warrick; Natalie S Callander; Peiman Hematti; Shigeki Miyamoto
Journal:  Mol Cancer Res       Date:  2022-09-02       Impact factor: 6.333

3.  Cereblon regulates NK cell cytotoxicity and migration via Rac1 activation.

Authors:  Cinzia Fionda; Helena Stabile; Rosa Molfetta; Andrea Kosta; Giovanna Peruzzi; Silvia Ruggeri; Alessandra Zingoni; Cristina Capuano; Alessandra Soriani; Rossella Paolini; Angela Gismondi; Marco Cippitelli; Angela Santoni
Journal:  Eur J Immunol       Date:  2021-09-18       Impact factor: 6.688

4.  Role of whole-body diffusion-weighted imaging in evaluation of multiple myeloma.

Authors:  Jiping Wang; Bei Zhang; Rongkui Zhang; Li Zhang; Wenyan Jiang; Yaqiu Jiang
Journal:  Medicine (Baltimore)       Date:  2021-09-03       Impact factor: 1.817

Review 5.  Targeting NK Cell Inhibitory Receptors for Precision Multiple Myeloma Immunotherapy.

Authors:  Helmi Alfarra; Jackson Weir; Stacy Grieve; Tony Reiman
Journal:  Front Immunol       Date:  2020-11-12       Impact factor: 7.561

6.  Activation of NF-κB signaling via cytosolic mitochondrial RNA sensing in kerotocytes with mitochondrial DNA common deletion.

Authors:  Xin Zhou; Ludvig J Backman; Patrik Danielson
Journal:  Sci Rep       Date:  2021-04-01       Impact factor: 4.379

Review 7.  Natural Killer Cells in the Malignant Niche of Multiple Myeloma.

Authors:  Ondrej Venglar; Julio Rodriguez Bago; Benjamin Motais; Roman Hajek; Tomas Jelinek
Journal:  Front Immunol       Date:  2022-01-11       Impact factor: 7.561

8.  Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition.

Authors:  Sara Petillo; Cristina Capuano; Rosa Molfetta; Cinzia Fionda; Abdelilah Mekhloufi; Chiara Pighi; Fabrizio Antonangeli; Alessandra Zingoni; Alessandra Soriani; Maria Teresa Petrucci; Ricciarda Galandrini; Rossella Paolini; Angela Santoni; Marco Cippitelli
Journal:  Cell Death Dis       Date:  2021-09-04       Impact factor: 8.469

9.  GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells.

Authors:  Andrea Kosta; Abdelilah Mekhloufi; Lorenzo Lucantonio; Alessandra Zingoni; Alessandra Soriani; Marco Cippitelli; Angela Gismondi; Francesca Fazio; Maria Teresa Petrucci; Angela Santoni; Helena Stabile; Cinzia Fionda
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

10.  A novel microRNA signature for the detection of melanoma by liquid biopsy.

Authors:  Claudia Sabato; Teresa Maria Rosaria Noviello; Anna Maria Di Giacomo; Elisabetta Ferretti; Alessia Covre; Sandra Coral; Francesca Pia Caruso; Zein Mersini Besharat; Elena Splendiani; Laura Masuelli; Cecilia Battistelli; Alessandra Vacca; Giuseppina Catanzaro; Agnese Po; Andrea Anichini; Michele Maio; Michele Ceccarelli
Journal:  J Transl Med       Date:  2022-10-15       Impact factor: 8.440

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.